Phibro Animal Health Corporation | Small-cap | Healthcare
$39.62
-3.81%
| Phibro Animal Health Stock Comparison:
Phibro Animal Health vs ZoetisPhibro Animal Health vs Haleon Plc - ADRPhibro Animal Health vs BioCrystPhibro Animal Health vs BGMPhibro Animal Health vs HarrowPhibro Animal Health vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 378.7M
Gross Profit 110.0M 29.05%
Operating Income 33.7M 8.90%
Net Income 17.2M 4.55%
EPS (Diluted) $0.42

Balance Sheet Metrics

Total Assets 1.4B
Total Liabilities 1.1B
Shareholders Equity 285.7M
Debt to Equity 3.76

Cash Flow Metrics

Operating Cash Flow 239.0K
Free Cash Flow 8.1M

Revenue & Profitability Trend

Phibro Animal Health Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.3B1.0B977.9M942.3M833.4M
Cost of Goods Sold i896.3M704.6M679.7M656.9M562.0M
Gross Profit i399.9M313.1M298.2M285.4M271.4M
Gross Margin % i30.9%30.8%30.5%30.3%32.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i289.5M259.8M226.4M206.4M196.5M
Other Operating Expenses i-----
Total Operating Expenses i289.5M259.8M226.4M206.4M196.5M
Operating Income i110.5M53.3M71.8M79.0M74.9M
Operating Margin % i8.5%5.2%7.3%8.4%9.0%
Non-Operating Items
Interest Income i2.6M4.5M3.4M816.0K838.0K
Interest Expense i33.2M22.0M17.9M12.1M11.9M
Other Non-Operating Income-7.9M-23.9M-2.5M5.2M4.5M
Pre-tax Income i68.0M10.9M54.1M72.3M66.5M
Income Tax i19.7M8.5M21.5M23.2M12.1M
Effective Tax Rate % i29.0%77.9%39.7%32.0%18.2%
Net Income i48.3M2.4M32.6M49.2M54.4M
Net Margin % i3.7%0.2%3.3%5.2%6.5%
Key Metrics
EBITDA i154.7M92.9M108.5M111.9M105.7M
EPS (Basic) i$1.19$0.06$0.81$1.21$1.34
EPS (Diluted) i$1.19$0.06$0.81$1.21$1.34
Basic Shares Outstanding i4050000040504000405040004050000040500000
Diluted Shares Outstanding i4050000040504000405040004050000040500000

Income Statement Trend

Phibro Animal Health Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i68.0M70.6M41.3M74.2M50.2M
Short-term Investments i9.0M44.0M40.0M17.0M43.0M
Accounts Receivable i228.0M169.5M163.5M166.5M146.9M
Inventory i444.4M265.9M277.6M259.2M216.3M
Other Current Assets61.2M51.0M63.4M49.3M42.5M
Total Current Assets i810.6M601.0M585.7M566.2M498.9M
Non-Current Assets
Property, Plant & Equipment i41.3M37.6M35.8M37.7M33.0M
Goodwill i155.8M154.1M161.5M170.3M167.6M
Intangible Assets i36.5M45.0M55.0M63.9M62.3M
Long-term Investments89.0K010.2M13.0M2.7M
Other Non-Current Assets45.8M27.6M18.2M16.0M20.1M
Total Non-Current Assets i550.3M381.2M385.7M365.5M342.4M
Total Assets i1.4B982.2M971.4M931.7M841.3M
Liabilities
Current Liabilities
Accounts Payable i138.2M85.6M73.9M95.6M68.4M
Short-term Debt i25.4M37.3M28.3M21.1M16.0M
Current Portion of Long-term Debt-----
Other Current Liabilities31.2M17.5M18.9M18.9M20.8M
Total Current Liabilities i293.5M204.1M176.0M190.8M164.1M
Non-Current Liabilities
Long-term Debt i736.2M488.2M481.6M449.4M410.7M
Deferred Tax Liabilities i19.5M14.2M12.1M9.3M6.6M
Other Non-Current Liabilities11.4M6.8M6.1M5.9M7.6M
Total Non-Current Liabilities i781.7M521.4M512.9M478.4M438.7M
Total Liabilities i1.1B725.5M688.9M669.3M602.8M
Equity
Common Stock i4.0K4.0K4.0K4.0K4.0K
Retained Earnings i272.7M243.9M260.9M247.7M218.0M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i285.7M256.6M282.5M262.4M238.5M
Key Metrics
Total Debt i761.6M525.5M510.0M470.5M426.7M
Working Capital i517.1M396.8M409.7M375.4M334.8M

Balance Sheet Composition

Phibro Animal Health Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i48.3M2.4M32.6M49.2M54.4M
Depreciation & Amortization i45.6M36.2M34.0M32.7M31.9M
Stock-Based Compensation i717.0K475.0K001.1M
Working Capital Changes i-68.7M20.9M-35.4M-47.8M-31.1M
Operating Cash Flow i27.0M51.6M29.5M34.5M56.8M
Investing Activities
Capital Expenditures i-----
Acquisitions i-286.5M-3.3M0-13.5M0
Investment Purchases i-14.0M-65.5M-40.0M-64.1M-74.0M
Investment Sales i49.0M61.5M17.0M91.5M86.0M
Investing Cash Flow i-250.4M-7.0M-22.2M14.5M10.7M
Financing Activities
Share Repurchases i-----
Dividends Paid i-19.4M-19.4M-19.4M-19.4M-19.4M
Debt Issuance i1.2B276.0M326.0M297.0M617.5M
Debt Repayment i-946.0M-263.3M-283.3M-256.4M-612.1M
Financing Cash Flow i207.1M-6.8M27.0M66.3M-91.0M
Free Cash Flow i41.8M46.4M-38.5M-5.4M19.0M
Net Change in Cash i-16.2M37.9M34.2M115.3M-23.4M

Cash Flow Trend

Phibro Animal Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 33.29
Forward P/E 21.07
Price to Book 5.62
Price to Sales 1.24
PEG Ratio 21.07

Profitability Ratios

Profit Margin 3.72%
Operating Margin 10.06%
Return on Equity 17.80%
Return on Assets 7.13%

Financial Health

Current Ratio 2.76
Debt to Equity 269.85
Beta 0.88

Per Share Data

EPS (TTM) $1.19
Book Value per Share $7.05
Revenue per Share $31.99

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
pahc1.6B33.295.6217.80%3.72%269.85
Zoetis 65.3B25.3613.1452.77%27.83%137.01
Haleon Plc - ADR 45.4B21.935.599.38%13.81%53.41
BioCryst 1.7B-18.40-3.9318.68%-6.41%-1.75
BGM 1.5B15.003.98-16.52%-26.32%0.22
Harrow 1.5B-80.4529.16-19.03%-4.49%469.08

Financial data is updated regularly. All figures are in the company's reporting currency.